Actions of Imocine 2 in details
Imocine 2 is an inhibitor of H+ K+ ATPase. This medication inhibits the activity of H+-K+-ATPase in gastric parietal cells and thus blocks the final stage of hydrochloric acid secretion. This leads to a reduction in basal and stimulated secretion, regardless of the nature of the stimulus. Due to the reduction of acid secretion omeprazole reduces or normalizes the effects of acid in the esophagus in patients with reflux esophagitis.
Imocine 2 has a bactericidal effect on Helicobacter pylori. Eradication of H. pylori when omeprazole used with antibiotics allows to quickly arrest the symptoms, to take a high degree of healing of damaged mucosa and persistent long-term remission and reduce the likelihood of bleeding from the gastrointestinal tract.
How should I take Imocine 2?
Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.
Take Imocine 2 with a full glass of water. Drink extra water while you are taking this medication to keep from getting dehydrated.
Imocine 2 is usually taken at the first sign of diarrhea, and again if diarrhea comes back. The first dose of Imocine 2 is usually twice as much as the following doses. Do not take this medication more than 3 times in 24 hours without your doctor's advice.
The Imocine 2 chewable tablet must be chewed before swallowing.
Shake the oral suspension (liquid) well just before you measure a dose. Measure the liquid with a special dose measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose measuring device, ask your pharmacist for one.
Immodium A-D Liquid and New Immodium A-D Liquid contain two different strengths of Imocine 2. If you switch from using one brand to using the other, follow the dosing instructions carefully. Immodium A-D Liquid also contains a small amount of alcohol, but New Immodium A-D Liquid does not.
It may take up to 48 hours before your symptoms improve. Keep using the medication as directed and tell your doctor if your symptoms do not improve after 10 days of treatment.
Store at room temperature away from moisture and heat. Do not freeze liquid Imocine 2.
Imocine 2 administration
Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.
Take Imocine 2 with a full glass of water. Drink extra water while you are taking this medication to keep from getting dehydrated.
Imocine 2 is usually taken at the first sign of diarrhea, and again if diarrhea comes back. The first dose of Imocine 2 is usually twice as much as the following doses. Do not take this medication more than 3 times in 24 hours without your doctor's advice.
The Imocine 2 chewable tablet must be chewed before swallowing.
Shake the oral suspension (liquid) well just before you measure a dose. Measure the liquid with a special dose measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose measuring device, ask your pharmacist for one.
Immodium A-D Liquid and New Immodium A-D Liquid contain two different strengths of Imocine 2. If you switch from using one brand to using the other, follow the dosing instructions carefully. Immodium A-D Liquid also contains a small amount of alcohol, but New Immodium A-D Liquid does not.
It may take up to 48 hours before your symptoms improve. Keep using the medication as directed and tell your doctor if your symptoms do not improve after 10 days of treatment.
Store at room temperature away from moisture and heat. Do not freeze liquid Imocine 2.
Imocine 2 pharmacology
In vitro and animal studies show that Imocine 2 hydrochloride acts by slowing intestinal motility and by affecting water and electrolyte movement through the bowel. Imocine 2 binds to the opiate receptor in the gut wall. Consequently, it inhibits the release of acetylcholine and prostaglandins, thereby reducing peristalsis, and increasing intestinal transit time. Imocine 2 increases the tone of the anal sphincter, thereby reducing incontinence and urgency.
In man, Imocine 2 hydrochloride prolongs the transit time of the intestinal contents. It reduces the daily fecal volume, increases the viscosity and bulk density, and diminishes the loss of fluid and electrolytes. Tolerance to the antidiarrheal effect has not been observed. Clinical studies have indicated that the apparent elimination half-life of Imocine 2 hydrochloride in man is 10.8 hours with a range of 9.1 to 14.4 hours. Plasma levels of unchanged drug remain below 2 nanograms per mL after the intake of a 2 mg Imocine 2 hydrochloride capsule. Plasma levels are highest approximately five hours after administration of the capsule and 2.5 hours after the liquid. The peak plasma levels of Imocine 2 were similar for both formulations. Elimination of Imocine 2 mainly occurs by oxidative N-demethylation. Cytochrome P450 (CYP450) isozymes, CYP2C8 and CYP3A4, are thought to play an important role in Imocine 2 N-demethylation process since quercetin (CYP2C8 inhibitor) and ketoconazole (CYP3A4 inhibitor) significantly inhibited the N-demethylation process in vitro by 40% and 90%, respectively. In addition, CYP2B6 and CYP2D6 appear to play a minor role in Imocine 2 N-demethylation. Excretion of the unchanged Imocine 2 and its metabolites mainly occurs through the feces. In those patients in whom biochemical and hematological parameters were monitored during clinical trials, no trends toward abnormality during Imocine 2 hydrochloride therapy were noted. Similarly, urinalyses, EKG and clinical ophthalmological examinations did not show trends toward abnormality.
References
- NCIt. "Loperamide: NCI Thesaurus (NCIt) provides reference terminology for many systems. It covers vocabulary for clinical care, translational and basic research, and public information and administrative activities.". https://ncit.nci.nih.gov/ncitbrowser... (accessed September 17, 2018).
- EPA DSStox. "Loperamide: DSSTox provides a high quality public chemistry resource for supporting improved predictive toxicology.". https://comptox.epa.gov/dashboard/ds... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Imocine 2 are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Imocine 2. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported administration
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
